The filtration fraction (FF)
FF = GFR/RPF
RPF = RBF * (1 - Hematocrit)
RPF = CLERANCE OF PAH
GFR = CLERANCE OF Creatinine OR INULIN
he clearance (C) of any given substance S can be calculated as:
Cs = ([Urine concentration of S] x [Urine flow rate]) / (Plasma concentration of S)
renal acid excretion
The kidneys can normally compensate somewhat for metabolic acidosis by increasing renal acid excretion. The major mechanisms of increased renal acid excretion include:
Increased H+ secretion: Intracellular acidosis leads to a direct increase in H+ secretion via increased activity of the apical Na+/H+ exchanger.
Increased HCO3− reabsorption: Carbonic anhydrase in the proximal tubular lumen facilitates reabsorption of filtered HCO3−. Each reabsorbed HCO3− is equivalent to the secretion of one H+. In metabolic acidosis, HCO3- is completely reabsorbed from the tubular fluid.
Increased acid buffer excretion: Urinary acid buffers, hydrogen phosphate (HPO42−) and ammonia (NH3), are used to trap H+ in the lumen in the form of H2PO4- and NH4+, vastly increasing the amount of acid that can be excreted in the urine. With chronic acidosis, proximal tubular cells greatly increase NH3 production to increase acid excretion capacity.
Pregnancy and GFR
Pregnancy results in significant plasma expansion and widespread vasodilation, leading to increased renal plasma flow and glomerular filtration rates.
Serum creatinine is reduced by approximately 0.4 mg/dL in this population; therefore, a rise in serum creatinine, even to levels that are normal in nonpregnant patients, represents significant renal dysfunction.
CKD can cause hyperphosphatemia AND LOW EPO
due to impaired renal excretion of phosphorus.
Elevated blood phosphate triggers the release of fibroblast growth factor 23, which lowers calcitriol (1,25-dihydroxyvitamin )production and intestinal calcium absorption.
Chronic kidney disease usually causes hyperphosphatemia (binds serum Ca2+) and low 1,25-dihydroxyvitamin D (decreases intestinal Ca2+ absorption and Ca2+ release from bone). The resulting hypocalcemia stimulates release of parathyroid hormone, causing secondary hyperparathyroidism.. IMPORTANTTTT
Osteitis fibrosa cystica is a form of renal osteodystrophy characterized by abnormally high bone turnover caused by chronic parathyroid hormone stimulation of osteoclasts to a greater degree than that of osteoblasts. Bone biopsy would show an increased number of both osteoclasts and osteoblasts.
Fibroblast growth factor 23 (FGF23) is secreted ( by osteocytes) in response to hyperphosphatemia and lowers plasma phosphate by 1)reducing intestinal absorption(vit d) and 2)renal reabsorption of phosphate. FGF23 levels are useful as an early marker of abnormal phosphate metabolism in patients with CKD.
Renal excretion of a drug is dependent on:
Glomerular filtration (reduced with low renal blood flow, kidney disease, and high drug protein binding)
Renal tubular secretion (reduced by coadministration of drugs with overlapping substrate specificity)
Tubular reabsorption (may be altered by changes in urine p
Erythropoietin
Erythropoietin (EPO) is produced primarily by peritubular fibroblast cells in the renal cortex (Peritubular interstitial cells) in response to decreased renal oxygen delivery
LOW IN CKD NORMAL WITH AGING
side effect : venous thrombosis and HTN
Glomerular filtration rate (GFR)
can be assessed using an ideal filtration marker that is freely filtered across the glomerulus and is not metabolized, secreted, or reabsorbed by the kidney tubules. In common practice, GFR is estimated using creatinine clearance. However, creatinine is actively secreted by the proximal tubules, so uncorrected creatinine clearance overestimates the GFR by approximately 10%-20%
AFFERANT VS EFFERANT CONSTRICTION
Angiotensin II preferentially constricts the efferent arteriole, resulting in an increased hydrostatic pressure gradient and increased net filtration pressure.
Alpha-1 receptors are located mainly in the afferent arteriole; alpha agonists (eg, epinephrine, norepinephrine) result in constriction of the afferent arteriole, which reduces hydrostatic pressure and leads to lower net filtration pressures.
Prostaglandins (eg, prostaglandin E2) are responsible for dilation of the afferent arteriole.
NSAIDs Inhibition of prostaglandin synthesis,, results in constriction of the afferent arteriole, leading to reduced hydrostatic pressure and a lower net filtration pressure.
Albumin is not filtered across the glomerular capillary and would increase the oncotic pressure gradient, resulting in a lower net filtration pressure.
Refeeding syndrome
occurs after the reintroduction of carbohydrates in patients with chronic malnourishment, which stimulates insulin secretion and drives phosphorus intracellularly in an effort to maintain cellular energy metabolism (eg, ATP production); this redistribution of phosphorus can result in severe hypophosphatemia
ADH
Antidiuretic hormone acts on the medullary segment of the collecting duct (principal cells) to increase urea and water reabsorption, allowing for the production of maximally concentrated urine
he medullary interstitium is the region of highest osmolarity in the kidney
This hormone stimulates V2 receptors causing translocation of aquaporin 2 channels into the apical cell membrane
fluid in the distal tubules is the most dilute (lowest osmolarity, approaching 100 mOsm/L).
DIABETES INSIPIDUS DI
1))CENTRAL DI
2)) Nephrogenic DI is characterized by polyuria, dilute urine (low urine specific gravity), hypernatremia, and high antidiuretic hormone.
Treatment includes thiazide diuretics and replacement of water losses.
SIADH
manifests with low serum osmolality, hyponatremia, high urine osmolality, and high urine sodium.
IN CONTRAST WITH DI
Causes
CNS disturbances (stroke, hemorrhage, trauma)
Medications (eg, carbamazepine, SSRIs, NSAIDs)
Lung disease (eg, pneumonia)
Malignancy (eg, small-cell lung cancer)
Clinical findings
Nausea, forgetfulness (mild hyponatremia)
Seizures, coma (severe hyponatremia)
Euvolemia (eg, moist mucous membranes, no edema, no JVD)
obstruction WITH FGR AN FF
Acute ureteral constriction or obstruction decreases the glomerular filtration rate and filtration fraction.
BY increased renal tubular hydrostatic pressure. As the intraglomerular capillary hydrostatic pressure is unchanged, this results in a decreased hydrostatic pressure gradient leading to a reduction in glomerular filtration
Consequences of VUR:
↑ Risk of chronic pyelonephritis
Renal inflammation from infection & ↑ hydrostatic pressure
Scarring pattern:
Most severe at upper & lower poles (compound papillae always open → more susceptible)
Mid-kidney papillae less affected (simple papillae closed at baseline).
Long-term: Reflux nephropathy → secondary hypertension
osteoblasts and PTH
PTH receptors activation causes osteoblasts to increase production of receptor activator of (RANK-L) and monocyte colony-stimulating factor. These factors stimulate osteoclastic precursors to differentiate into bone-resorbing osteoclasts.
PTH also decreases the release of (OPG), a decoy receptor for RANK-L; therefore, lower levels of OPG allow for more interaction between RANK-L and the osteoclastic receptor, increasing bone resorption and releasing calcium and phosphate into circulation
intermittent administration of recombinant PTH analogs induces a greater increase in osteoblast activity in proportion to osteoclast activity and a net increase in new bone formation. Teriparatide is a recombinant PTH analog used to treat osteoporosis.
PTH decreases proximal (note) tubular reabsorption of phosphate
and increases calcium reabsorption in the distal convoluted tubule and collecting duct.(note)
vascular calcifications (VCs)
VCs occur when metabolic insults (eg, electrolyte abnormalities, dyslipidemia, oxidative stress, uremia) cause smooth muscle cells in the arterial media to differentiate into osteoblast-like cells (ie, osteogenic differentiation), resulting in active deposition of calcium salts within the vessels
CKD : Electrolyte abnormalities: Hyperphosphatemia and/or hypercalcemia promote calcification by stimulating osteogenic differentiation
Salicylate poisoning ASPIRIN
mixed primary respiratory alkalosis and primary anion gap metabolic acidosis
by
increased respiratory rate
increased production of lactic acid (uncouples oxidative phosphorylation)
Symptoms include tinnitus, tachypnea, hyperthermia, vomiting, and altered mental status.
Hypokalemia
*β-adrenergic activity
Pharmacologic: albuterol, dobutamine
Stress-induced: alcohol withdrawal, acute MI
*Alkalosis (respiratory or metabolic)
*↑ Cell reproduction (eg, acute myeloid leukemia, GM-CSF therapy)
Hyperaldosteronism
Diuretics (loop, thiazide)
Renal tubular acidosis (type 1 and type 2)
Hypomagnesemia (induces renal K⁺ wasting)
potassium (K⁺)
Fixed handling (not regulated by K⁺ load):
Bowman’s capsule → freely filtered (100%)
Proximal tubule → reabsorbs ~65%
Thick ascending limb (Na⁺/K⁺/2Cl⁻ cotransporter) → reabsorbs 25–30% → ~5–10% remains
Regulated handling (site of control):
Late distal & cortical collecting tubules
Principal cells → secrete K⁺ (stimulated by ↑ dietary K⁺ & aldosterone)
α-intercalated cells → reabsorb K⁺ (via H⁺/K⁺-ATPase; stimulated by hypokalemia)
hemodialysis. What factors determine the rate of molecular diffusion?
Concentration gradient (ΔC)
Membrane surface area (A)
Solubility of the substance
Membrane thickness (Δx)
Molecular weight (√MW)
SGLT-2 inhibitors e.g Canagliflozin
Glucose is reabsorbed from the proximal tubule by sodium-glucose cotransporter-2 (SGLT-2). Normally, nearly all filtered glucose is reabsorbed.
SGLT-2 inhibitors lower the threshold at which filtered glucose can be fully reabsorbed; this increases urinary glucose losses and lowers blood glucose levels. RISK OF HYPOGLYCEMIA
transport maximum (Tmax) AND GLUCOSE
At normal plasma concentrations of glucose, the renal tubules reabsorb the entire filtered load of glucose because it is below the maximum tubular reabsorption ability (transport maximum of glucose).
At higher plasma concentrations, glucose is excreted when the filtered amount exceeds the transport maximum.
The serum concentration at which glucosuria begins, called the threshold of glucose, is approximately 200 mg/dL.
DM effect
1))Type 4 Renal Tubular Acidosis (RTA)
Cause: ↓ Aldosterone effect (deficiency or resistance)
Hyperkalemia → impaired K⁺ excretion
Non–anion gap metabolic acidosis → impaired H⁺ excretion (↓ ammonium)
↓ Na⁺ reabsorption → mild total body sodium loss (but serum Na⁺ often normal due to ADH)
2)) diabetic nephropath
Progression:
1.Hyperfiltration
INCREASE GFR ,Glomerular hypertrophy
2.incpint DN
Basement membrane thickening, mesangial expansion, podocyte injury
HTN
Microalbuminuria → Macroalbuminuria (>300 mg/day)
4.Overt DN
DECREASE GFR
Overt Proteinuria (Nephrotic)
KW lesion
mesangial sclerosis (Glomerulosclerosis) → ↓ GFR → ESRD
Homogeneous deposition of eosinophilic hyaline material in the intima and media of small arteries and arterioles characterizes hyaline arteriolosclerosis.
This is typically produced by untreated or poorly controlled hypertension and/or diabetes.
Glycosuria is seen at blood glucose levels >200-300 mg/dL due to saturation of renal glucose transporters. Glycosuria reflects poor glycemic control but does not correlate with the degree of renal damage in DN.
primary nocturnal enuresis
Definition: Bed-wetting in a child ≥5 years who has never achieved sustained nighttime continence.
Pathogenesis:
1)Maturational delay in bladder control:
↓ Awareness of bladder filling
↓ Cortical suppression of bladder contractions
Poor coordination of sphincter & detrusor (pontine micturition center)
2) ↑ Overnight urine production (↓ ADH activity, excessive evening fluids)
3)Reduced functional bladder capacity
AKI :: Acute interstitial nephritis
Causes
Antibiotics (eg, beta-lactam, sulfonamide, rifampin)
Proton pump inhibitors
NSAIDs
Diuretics
Other: Autoimmune diseases, Mycoplasma, Legionella
Clinical features
Rash, fever, or asymptomatic
New drug exposure IMPORTANT
Laboratory findings
Acute kidney injury
Pyuria, hematuria, WBC casts IMPORTANT
Eosinophilia, urinary eosinophils IMPORTANT
Renal biopsy: Inflammatory interstitial infiltrate and edema
Symptoms typically resolve with withdrawal of the offending agent.
Microscopy: patchy interstitial inflammation, tubular atrophy, fibrosis
Gross: shrunken kidneys, irregular contours, distorted calyces, papillary necrosis